The Roles of N6-Methyladenosine Modification and Its Regulators in Male Reproduction

Infertility affects an estimated 10 to 15 percent of couples worldwide, with approximately half of the cases attributed to male-related issues. Most men diagnosed with infertility exhibit symptoms such as oligospermia, asthenospermia, azoospermia, and compromised sperm quality. Spermatogenesis is a complex and tightly coordinated process of germ cell differentiation, precisely regulated at transcriptional, posttranscriptional, and translational levels to ensure stage-specific gene expression during the development of spermatogenic cells and normal spermiogenesis. N6-methyladenosine (m6A) stands out as the most prevalent modification on eukaryotic mRNA, playing pivotal roles in various biological processes, including mRNA splicing, transportation, and translation. RNA methylation modification is a dynamic and reversible process primarily mediated by “writers”, removed by “erasers”, and recognized by “readers”. In mammals, the aberrant methylation modification of m6A on mRNA is associated with a variety of diseases, including male infertility. However, the precise involvement of disrupted m6A modification in the pathogenesis of human male infertility remains unresolved. Intriguingly, a significant correlation has been found between the expression levels of m6A regulators in the testis and the severity of sperm concentration, motility, and morphology. Aberrant expression patterns of m6A regulatory proteins have been detected in anomalous human semen samples, including those of oligospermia, asthenozoospermia, and azoospermia. Furthermore, the examination of both sperm samples and testicular tissues revealed abnormal mRNA m6A modification, leading to reduced sperm motility and concentration in infertile men. Consequently, it is hypothesized that dysregulation of m6A modification might serve as an integral link in the mechanism of male infertility. This paper presents a comprehensive review of the recent discoveries regarding the spatial and temporal expression dynamics of m6A regulators in testicular tissues and the correlation between deregulated m6A regulators and human male infertility. Previous studies predominantly utilized constitutive or conditional knockout animal models for testicular phenotypic investigations. However, gene suppression in additional tissues could potentially influence the testis in constitutive knockout models. Furthermore, considering the compromised spermatogenesis observed in constitutive animals, distinguishing between the indirect effects of gene depletion on testicular development and its direct impact on the spermatogenic process is challenging, due to their intricate relationship. Such confounding factors might compromise the validity of the findings. To address this challenge, an inducible and conditional gene knockout model may serve as a superior approach. To date, nearly all reported studies have concentrated solely on the level changes of m6A and its regulators in germs cells, while the understanding of the function of m6A modification in testicular somatic cells remains limited. Testicular somatic cells, including peritubular myoid cells, Sertoli cells, and Leydig cells, play indispensable roles during spermatogenesis. Hence, comprehensive exploration of m6A modification within these cells as an additional crucial regulatory mechanism is warranted. In addition, exploration into the presence of unique methylation mechanisms or m6A regulatory factors within the testes is warranted. To elucidate the role of m6A modification in germ cells and testicular somatic cells, detailed experimental strategies need to be implemented. Among them, manipulation of the levels of key enzymes involved in m6A methylation and demethylation might be the most effective approach. Moreover, comprehensive analysis of the gene expression profiles involved in various signaling pathways, such as Wnt/β-catenin, Ras/MAPK, and Hippo, in m6A-modified germ cells and testicular somatic cells can provide more insight into its regulatory role in the spermatogenesis process. Further research in this area could provide valuable insights for developing innovative strategies to treat male infertility. Finally, considering the mitigation impact of m6A imbalance regulation on disease, investigation concerning whether restoring the equilibrium of m6A modification regulation can restore normal spermatogenesis function is essential, potentially elucidating the pivotal clinical significance of m6A modulation in male infertility.

 

Keywords: Spermatogenesis, N6-methyladenosine, RNA modifications, Male infertility, Epigenetics, Review

 

EISENBERG M L, ESTEVES S C, LAMB D J, et al. Male infertility. Nat Rev Dis Primers, 2023, 9(1): 49. doi: 10.1038/s41572-023-00459-w.

DELAUNAY S, HELM M, FRYE M. RNA modifications in physiology and disease: towards clinical applications. Nat Rev Genet, 2024, 25(2): 104–122. doi: 10.1038/s41576-023-00645-2.

OERUM S, MEYNIER V, CATALA M, et al. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res, 2021, 49(13): 7239–7255. doi: 10.1093/nar/gkab378.

CAI Z, NIU Y, LI H. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility. Mol Hum Reprod, 2021, 27(6): gaab020. doi: 10.1093/molehr/gaab020.

VALLET-BUISAN M, MECCA R, JONES C, et al. Contribution of semen to early embryo development: fertilization and beyond. Hum Reprod Update, 2023, 29(4): 395–433. doi: 10.1093/humupd/dmad006.

LIU Y, YANG D, LIU T, et al. N6-methyladenosine-mediated gene regulation and therapeutic implications. Trends Mol Med, 2023, 29(6): 454–467. doi: 10.1016/j.molmed.2023.03.005.

FLAMAND M N, TEGOWSKI M, MEYER K D. The proteins of mRNA modification: writers, readers, and erasers. Annu Rev Biochem, 2023, 92: 145–173. doi: 10.1146/annurev-biochem-052521-035330.

ZHOU H, YIN K, ZHANG Y, et al. The RNA m6A writer METTL14 in cancers: roles, structures, and applications. Biochim Biophys Acta Rev Cancer, 2021, 1876(2): 188609. doi: 10.1016/j.bbcan.2021.188609.

WANG T, KONG S, TAO M, et al. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer, 2020, 19(1): 88. doi: 10.1186/s12943-020-01204-7.

LEI K, LIN S, YUAN Q. N6-methyladenosine (m6A) modification of ribosomal RNAs (rRNAs): critical roles in mRNA translation and diseases. Genes Dis, 2023, 10(1): 126–134. doi: 10.1016/j.gendis.2021.10. 005.

SATTERWHITE E R, MANSFIELD K D. RNA methyltransferase METTL16: targets and function. Wiley Interdiscip Rev RNA, 2022, 13(2): e1681. doi: 10.1002/wrna.1681.

YANG Z, YU G L, ZHU X, et al. Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders. Genes Dis, 2022, 9(1): 51–61. doi: 10.1016/j.gendis.2021.01.005.

SENDINC E, SHI Y. RNA m6A methylation across the transcriptome. Mol Cell, 2023, 83(3): 428–441. doi: 10.1016/j.molcel.2023.01.006.

QU J, YAN H, HOU Y, et al. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol, 2022, 15(1): 8. doi: 10.1186/s13045-022-01224-4.

CHEN L, GAO Y, XU S, et al. N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms. Front Immunol, 2023, 14: 1162607. doi: 10.3389/fimmu.2023.1162607.

LIU T, WEI Q, JIN J, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res, 2020, 48(7): 3816–3831. doi: 10.1093/nar/gkaa048.

SIKORSKI V, SELBERG S, LALOWSKI M, et al. The structure and function of YTHDF epitranscriptomic m6A readers. Trends Pharmacol Sci, 2023, 44(6): 335–353. doi: 10.1016/j.tips.2023.03.004.

LI L, KRASNYKOV K, HOMOLKA D, et al. The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of m6A recognition. Mol Cell, 2022, 82(9): 1678–1690.e1612. doi: 10.1016/j. molcel.2022.02.034.

LIU Y, SHI S L. The roles of hnRNP A2/B1 in RNA biology and disease. Wiley Interdiscip Rev RNA, 2021, 12(2): e1612. doi: 10.1002/wrna.1612.

ZHU T Y, HONG L L, LING Z Q. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res, 2023, 11(1): 62. doi: 10.1186/s40364-023-00499-0.

BOHLEN J, ROIUK M, NEFF M, et al. PRRC2 proteins impact translation initiation by promoting leaky scanning. Nucleic Acids Res, 2023, 51(7): 3391–3409. doi: 10.1093/nar/gkad135.

MURAKAMI S, JAFFREY S R. Hidden codes in mRNA: control of gene expression by m6A. Mol Cell, 2022, 82(12): 2236–2251. doi: 10.1016/j. molcel.2022.05.029.

XU K, YANG Y, FENG G H, et al. Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation. Cell Res, 2017, 27(9): 1100–1114. doi: 10.1038/cr.2017.100.

LIN Z, HSU P J, XING X, et al. Mettl3-/Mettl14-mediated mRNA N6-methyladenosine modulates murine spermatogenesis. Cell Res, 2017, 27(10): 1216–1230. doi: 10.1038/cr.2017.117.

ZHENG G, DAHL J A, NIU Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell, 2013, 49(1): 18–29. doi: 10.1016/j.molcel.2012.10.015.

TANG C, KLUKOVICH R, PENG H, et al. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells. Proc Natl Acad Sci, 2018, 115(2): E325–E333. doi: doi: 10.1073/pnas.1717794115.

HUANG T, GAO Q, FENG T, et al. FTO knockout causes chromosome instability and G2/M arrest in mouse GC-1 cells. Front Genet, 2019, 9: 732. doi: 10.3389/fgene.2018.00732.

WU Y, LI J, LI C, et al. Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner. J Biol Chem, 2023, 299(6): 104783. doi: 10.1016/j.jbc. 2023.104783.

LI Y, SU R, DENG X, et al. FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends Cancer, 2022, 8(7): 598–614. doi: 10.1016/j.trecan.2022.02.010.

COHEN P E, SOH Y Q S, MIKEDIS M M, et al. Meioc maintains an extended meiotic prophase I in mice. PLoS Genet, 2017, 13(4): e1006704. doi: 10.1371/journal.pgen.1006704.